Product Information
BUPRENORPHINE 20 MCG/HR PATCH is a generic product labeled by Alvogen Inc., priced at $57.9346 per EA under NDC 47781040804. Its NADAC has been published 190 times since Nov 9, 2022.
Strength
20 ug/h
Manufacturer
Alvogen Inc.NDC
47781040804
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Last Updated
6/17/2026
Active Ingredients
BUPRENORPHINEApproval Type
Generic (ANDA)
FDA Application
ANDA207490On Market Since
5/17/2022
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 20 MCG/HR PATCH has been published 190 times since Nov 9, 2022, and over the history we have for it it has declined 38.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $57.9346 per EA |
|---|---|
| All-time high | $100.2806 (Feb 15, 2023) |
| All-time low | $42.3325 (Jul 17, 2024) |
| 52-week high | $58.2405 |
| 52-week low | $52.6588 |
| Median price | $59.2160 |
| Average price | $66.7368 |
| Largest weekly change | +51.6% (Aug 21, 2024) |
| Weeks tracked | 190 |
| Tracking since | Nov 9, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 20 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 20 MCG/HR PATCH, manufactured by Alvogen Inc., is $57.9346 per EA (NDC 47781040804), effective Jun 24, 2026.
How has the price of BUPRENORPHINE 20 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 20 MCG/HR PATCH has declined 38.8%. It has been tracked across 190 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 20 MCG/HR PATCH?
Since Nov 9, 2022, the NADAC for BUPRENORPHINE 20 MCG/HR PATCH has ranged from a low of $42.3325 (Jul 17, 2024) to a high of $100.2806 (Feb 15, 2023), with a median of $59.2160 per EA.
Are there cheaper alternatives to BUPRENORPHINE 20 MCG/HR PATCH?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BUPRENORPHINE 20 MCG/HR PATCH, but none are currently priced below it.
Who manufactures BUPRENORPHINE 20 MCG/HR PATCH?
BUPRENORPHINE 20 MCG/HR PATCH (NDC 47781040804) is labeled by Alvogen Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification